According to Arcturus Therapeutics 's latest financial reports the company's current EPS (TTM) is $4.32. In 2022 the company made an earnings per share (EPS) of $0.49 an increase over its 2021 EPS that were of -$11.04.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $4.15 | 755.78% |
2022 | $0.49 | -104.39% |
2021 | -$11.04 | 121.14% |
2020 | -$4.99 | 69.08% |
2019 | -$2.95 | -4.17% |
2018 | -$3.08 | -37.49% |
2017 | -$4.93 | -44.53% |
2016 | -$8.89 | -1.11% |
2015 | -$8.99 | -62.66% |
2014 | -$24.07 | 163.71% |
2013 | -$9.13 |